
Steven Michael Cernoch
Examiner (ID: 14939, Phone: (571)270-3540 , Office: P/3752 )
| Most Active Art Unit | 3752 |
| Art Unit(s) | 3709, 4114, 3752 |
| Total Applications | 834 |
| Issued Applications | 420 |
| Pending Applications | 79 |
| Abandoned Applications | 358 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20378766
[patent_doc_number] => 20250361259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-27
[patent_title] => AMORPHOUS FORM OF REDUCED ss-NICOTINAMIDE MONONUCLEOTIDE CALCIUM SALT, AND PREPARATION METHOD AND USE THEREFOR
[patent_app_type] => utility
[patent_app_number] => 19/262831
[patent_app_country] => US
[patent_app_date] => 2025-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19262831
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/262831 | AMORPHOUS FORM OF REDUCED ss-NICOTINAMIDE MONONUCLEOTIDE CALCIUM SALT, AND PREPARATION METHOD AND USE THEREFOR | Jul 7, 2025 | Pending |
Array
(
[id] => 20005875
[patent_doc_number] => 20250144097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES WITH DIABETES
[patent_app_type] => utility
[patent_app_number] => 19/003429
[patent_app_country] => US
[patent_app_date] => 2024-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19003429
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/003429 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES WITH DIABETES | Dec 26, 2024 | Pending |
Array
(
[id] => 19916177
[patent_doc_number] => 12291530
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-05-06
[patent_title] => GLP-1R agonist and therapeutic method thereof
[patent_app_type] => utility
[patent_app_number] => 18/885065
[patent_app_country] => US
[patent_app_date] => 2024-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17620
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18885065
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/885065 | GLP-1R agonist and therapeutic method thereof | Sep 12, 2024 | Issued |
Array
(
[id] => 19570767
[patent_doc_number] => 20240375059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => METAL-ORGANIC FRAMEWORK (MOF)-801@CHITOSAN (CS) PERVAPORATION MEMBRANE AND USE THEREOF IN METHANOL/DIMETHYL CARBONATE SEPARATION
[patent_app_type] => utility
[patent_app_number] => 18/657820
[patent_app_country] => US
[patent_app_date] => 2024-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 341
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657820
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/657820 | METAL-ORGANIC FRAMEWORK (MOF)-801@CHITOSAN (CS) PERVAPORATION MEMBRANE AND USE THEREOF IN METHANOL/DIMETHYL CARBONATE SEPARATION | May 7, 2024 | Pending |
Array
(
[id] => 19403592
[patent_doc_number] => 20240287103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => WATER-REPELLENT PROTECTIVE FILM-FORMING AGENT, WATER-REPELLENT PROTECTIVE FILM-FORMING CHEMICAL SOLUTION, AND WAFER SURFACE TREATMENT METHOD
[patent_app_type] => utility
[patent_app_number] => 18/583454
[patent_app_country] => US
[patent_app_date] => 2024-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18583454
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/583454 | WATER-REPELLENT PROTECTIVE FILM-FORMING AGENT, WATER-REPELLENT PROTECTIVE FILM-FORMING CHEMICAL SOLUTION, AND WAFER SURFACE TREATMENT METHOD | Feb 20, 2024 | Pending |
Array
(
[id] => 19359278
[patent_doc_number] => 20240261312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => Method and compositions for treating animal viral infections
[patent_app_type] => utility
[patent_app_number] => 18/438667
[patent_app_country] => US
[patent_app_date] => 2024-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18438667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/438667 | Method and compositions for treating animal viral infections | Feb 11, 2024 | Pending |
Array
(
[id] => 19345157
[patent_doc_number] => 20240254120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => EP4 INHIBITORS AND SYNTHESIS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/538687
[patent_app_country] => US
[patent_app_date] => 2023-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18538687
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/538687 | EP4 INHIBITORS AND SYNTHESIS THEREOF | Dec 12, 2023 | Pending |
Array
(
[id] => 18752560
[patent_doc_number] => 20230355838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => Soft Tissue Filler and Methods
[patent_app_type] => utility
[patent_app_number] => 18/222106
[patent_app_country] => US
[patent_app_date] => 2023-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18222106
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/222106 | Soft Tissue Filler and Methods | Jul 13, 2023 | Pending |
Array
(
[id] => 18844653
[patent_doc_number] => 20230407057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => LIQUID COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/334457
[patent_app_country] => US
[patent_app_date] => 2023-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18334457
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/334457 | LIQUID COMPOSITION | Jun 13, 2023 | Pending |
Array
(
[id] => 18690892
[patent_doc_number] => 20230321054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => COMPOSITIONS AND METHODS FOR CANCER AND TUMOR TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/188348
[patent_app_country] => US
[patent_app_date] => 2023-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188348
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/188348 | COMPOSITIONS AND METHODS FOR CANCER AND TUMOR TREATMENT | Mar 21, 2023 | Abandoned |
Array
(
[id] => 19246910
[patent_doc_number] => 20240197894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => RECOMBINANT HUMAN SERUM ALBUMIN-THERAPEUTIC DRUG CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 18/117661
[patent_app_country] => US
[patent_app_date] => 2023-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18117661
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/117661 | RECOMBINANT HUMAN SERUM ALBUMIN-THERAPEUTIC DRUG CONJUGATE | Mar 5, 2023 | Pending |
Array
(
[id] => 19359376
[patent_doc_number] => 20240261410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => SODIUM DEOXYCHOLATE BILE ACID AS ANTIBIOTIC CARRIER
[patent_app_type] => utility
[patent_app_number] => 18/166114
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166114
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166114 | SODIUM DEOXYCHOLATE BILE ACID AS ANTIBIOTIC CARRIER | Feb 7, 2023 | Pending |
Array
(
[id] => 18565675
[patent_doc_number] => 20230256002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => Hard lozenge made with dietary fiber
[patent_app_type] => utility
[patent_app_number] => 18/164837
[patent_app_country] => US
[patent_app_date] => 2023-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164837
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/164837 | Hard lozenge made with dietary fiber | Feb 5, 2023 | Abandoned |
Array
(
[id] => 19649992
[patent_doc_number] => 12171752
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Methods of treating post-COVID condition(s)
[patent_app_type] => utility
[patent_app_number] => 18/103983
[patent_app_country] => US
[patent_app_date] => 2023-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9945
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18103983
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/103983 | Methods of treating post-COVID condition(s) | Jan 30, 2023 | Issued |
Array
(
[id] => 18536001
[patent_doc_number] => 20230241088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => COMPOSITION FOR PREVENTING OR TREATING LUNG CANCER COMPRISING ORTHO-TOPOLIN RIBOSIDE AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/096575
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5494
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096575
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/096575 | COMPOSITION FOR PREVENTING OR TREATING LUNG CANCER COMPRISING ORTHO-TOPOLIN RIBOSIDE AS ACTIVE INGREDIENT | Jan 12, 2023 | Abandoned |
Array
(
[id] => 18418498
[patent_doc_number] => 20230172956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => COMBINATORIAL THERAPY FOR USE IN INDUCING IMMUNOGENIC CELL DEATH IN CANCER CELLS
[patent_app_type] => utility
[patent_app_number] => 18/075621
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18075621
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/075621 | Combinatorial therapy for use in inducing immunogenic cell death in cancer cells | Dec 5, 2022 | Issued |
Array
(
[id] => 18404533
[patent_doc_number] => 20230165884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => METHOD AND COMPOSITION FOR TREATING ALZHEIMERS
[patent_app_type] => utility
[patent_app_number] => 18/059383
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18059383
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/059383 | METHOD AND COMPOSITION FOR TREATING ALZHEIMERS | Nov 27, 2022 | Pending |
Array
(
[id] => 18657674
[patent_doc_number] => 20230303614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/048407
[patent_app_country] => US
[patent_app_date] => 2022-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048407
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/048407 | CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | Oct 19, 2022 | Pending |
Array
(
[id] => 18449476
[patent_doc_number] => 20230190752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME
[patent_app_type] => utility
[patent_app_number] => 18/045744
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045744
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045744 | COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME | Oct 10, 2022 | Pending |
Array
(
[id] => 19947063
[patent_doc_number] => 12318401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy
[patent_app_type] => utility
[patent_app_number] => 17/956701
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 21
[patent_no_of_words] => 0
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17956701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/956701 | Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy | Sep 28, 2022 | Issued |